BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 12234947)

  • 1. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS).
    Hodis HN; Mack WJ; LaBree L; Mahrer PR; Sevanian A; Liu CR; Liu CH; Hwang J; Selzer RH; Azen SP;
    Circulation; 2002 Sep; 106(12):1453-9. PubMed ID: 12234947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study.
    Salonen RM; Nyyssönen K; Kaikkonen J; Porkkala-Sarataho E; Voutilainen S; Rissanen TH; Tuomainen TP; Valkonen VP; Ristonmaa U; Lakka HM; Vanharanta M; Salonen JT; Poulsen HE;
    Circulation; 2003 Feb; 107(7):947-53. PubMed ID: 12600905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering.
    Azen SP; Qian D; Mack WJ; Sevanian A; Selzer RH; Liu CR; Liu CH; Hodis HN
    Circulation; 1996 Nov; 94(10):2369-72. PubMed ID: 8921775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis.
    Salonen JT; Nyyssönen K; Salonen R; Lakka HM; Kaikkonen J; Porkkala-Sarataho E; Voutilainen S; Lakka TA; Rissanen T; Leskinen L; Tuomainen TP; Valkonen VP; Ristonmaa U; Poulsen HE
    J Intern Med; 2000 Nov; 248(5):377-86. PubMed ID: 11123502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Melbourne Atherosclerosis Vitamin E Trial (MAVET): a study of high dose vitamin E in smokers.
    Magliano D; McNeil J; Branley P; Shiel L; Demos L; Wolfe R; Kotsopoulos D; McGrath B
    Eur J Cardiovasc Prev Rehabil; 2006 Jun; 13(3):341-7. PubMed ID: 16926662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oxidized LDL and C-reactive protein level in relation to carotid intima-media thickness in population with risk factors for atherosclerosis].
    Caparević Z; Kostić N; Ilić S; Radojković J; Marina Dj; Pencić B; Radojković I
    Srp Arh Celok Lek; 2009; 137(3-4):140-5. PubMed ID: 19459559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of plasma ox-LDL and carotid IMT may represent useful markers for atherosclerosis and may represent potential targets for therapeutic interventions.
    Savoiu G; Drăgan S; Cristescu C; Serban C; Noveanus L; Ionescu D; Nicola T; Duicu O; Raducan A; Voicu M
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):397-401. PubMed ID: 21491821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.
    Hodis HN; Mack WJ; Lobo RA; Shoupe D; Sevanian A; Mahrer PR; Selzer RH; Liu Cr CR; Liu Ch CH; Azen SP;
    Ann Intern Med; 2001 Dec; 135(11):939-53. PubMed ID: 11730394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral alpha-tocopherol supplementation inhibits lipid oxidation in established human atherosclerotic lesions.
    Carpenter KL; Kirkpatrick PJ; Weissberg PL; Challis IR; Dennis IF; Freeman MA; Mitchinson MJ
    Free Radic Res; 2003 Nov; 37(11):1235-44. PubMed ID: 14703736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of lifestyle modification on atherosclerotic progression determined by ultrasonographic change in the common carotid intima-media thickness.
    Markus RA; Mack WJ; Azen SP; Hodis HN
    Am J Clin Nutr; 1997 Apr; 65(4):1000-4. PubMed ID: 9094885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte, but not plasma, vitamin E concentration is associated with carotid intima-media thickening in asymptomatic men at risk for cardiovascular disease.
    Simon E; Gariepy J; Cogny A; Moatti N; Simon A; Paul JL
    Atherosclerosis; 2001 Nov; 159(1):193-200. PubMed ID: 11689221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.
    Salonen R; Nyyssönen K; Porkkala E; Rummukainen J; Belder R; Park JS; Salonen JT
    Circulation; 1995 Oct; 92(7):1758-64. PubMed ID: 7671358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.
    Furberg CD; Adams HP; Applegate WB; Byington RP; Espeland MA; Hartwell T; Hunninghake DB; Lefkowitz DS; Probstfield J; Riley WA
    Circulation; 1994 Oct; 90(4):1679-87. PubMed ID: 7734010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between carotid intima-media thickness and low-density lipoprotein size and susceptibility of low-density lipoprotein to oxidation in asymptomatic members of familial combined hyperlipidemia families.
    Liu ML; Ylitalo K; Nuotio I; Salonen R; Salonen JT; Taskinen MR
    Stroke; 2002 May; 33(5):1255-60. PubMed ID: 11988600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating oxidized low-density lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyperlipidemia families.
    Liu ML; Ylitalo K; Salonen R; Salonen JT; Taskinen MR
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1492-7. PubMed ID: 15205217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small low-density lipoprotein and small low-density lipoprotein/total low-density lipoprotein are closely associated with intima-media thickness of the carotid artery in Type 2 diabetic patients.
    Inukai T; Yamamoto R; Suetsugu M; Matsumoto S; Wakabayashi S; Inukai Y; Matsutomo R; Takebayashi K; Aso Y
    J Diabetes Complications; 2005; 19(5):269-75. PubMed ID: 16112502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.
    Lyons TJ; Jenkins AJ; Zheng D; Klein RL; Otvos JD; Yu Y; Lackland DT; McGee D; McHenry MB; Lopes-Virella M; Garvey WT;
    Diabet Med; 2006 Sep; 23(9):955-66. PubMed ID: 16922701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intima media thickness of the carotid arteries: early pointer to arteriosclerosis and therapeutic endpoint].
    Ludwig M; von Petzinger-Kruthoff A; von Buquoy M; Stumpe KO
    Ultraschall Med; 2003 Jun; 24(3):162-74. PubMed ID: 12817310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans.
    Nakamura T; Kawagoe Y; Matsuda T; Takahashi Y; Sekizuka K; Ebihara I; Koide H
    Kidney Blood Press Res; 2003; 26(3):185-91. PubMed ID: 12886046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of family history on relations between insulin resistance, LDL cholesterol and carotid IMT in healthy adults.
    Anderwald C; Stadler M; Golay A; Krebs M; Petrie J; Luger A;
    Heart; 2010 Aug; 96(15):1191-200. PubMed ID: 20639236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.